Milestone Pharmaceuticals Inc
Pharmaceuticals
Milestone Pharmaceuticals Inc (MIST) Stock News
The latest MIST headlines and market coverage — 3 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
MADONNA: CLUB CONFESSIONS AMSTERDAM WITH MISTR
Madonna performed at CLUB CONFESSIONS presented by MISTR during WorldPride Amsterdam on August 4, 2026, surprising fans with a special appearance by Kylie Minogue. The pair debuted a new version of 'Love Sensation' and performed 'Sorry' for the first time in over two decades. The event highlighted Madonna's continued support for the LGBTQ+ community and MISTR's free telemedicine platform offering HIV prevention and sexual healthcare services.
- GlobeNewswire Inc.·
MADONNA: CLUB CONFESSIONS NYC WITH MISTR
Madonna returned to New York City to celebrate her No.1 album Confessions II through CLUB CONFESSIONS, an immersive nightlife experience presented in partnership with MISTR, a telemedicine platform providing free HIV prevention and sexual healthcare services. The event, held at Knockdown Center, featured performances by Stuart Price, Honey Dijon, and other artists, drawing celebrities from music, fashion, and entertainment while raising awareness for LGBTQ+ health initiatives.
- GlobeNewswire Inc.·
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Avalyn Pharma announced completion of target enrollment of 375 patients in the Phase 2b MIST clinical trial of AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis. The global, randomized, double-blinded, placebo-controlled trial is evaluating two doses of AP01 against placebo, with primary endpoint measuring change in lung function at 52 weeks. Topline data is expected in the second half of 2027.